MANUEL ESTRADA: Open Payments
NPI 1932791878 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,476 in 195 payments from 14 companies in 2025. Trend: 2023 $883 · 2024 $2,167 · 2025 $3,476
Food & beverage: $3,476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $549 |
| Corium, LLC | 19 | $399 |
| Otsuka America Pharmaceutical, Inc. | 23 | $394 |
| E.R. Squibb & Sons, L.L.C. | 17 | $393 |
| Axsome Therapeutics, Inc. | 16 | $355 |
| Alkermes, Inc. | 42 | $354 |
| Supernus Pharmaceuticals, Inc. | 9 | $298 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $184 |
| Janssen Pharmaceuticals, Inc | 5 | $112 |
Products named: VRAYLAR, Azstarys, REXULTI, COBENFY, Auvelity, ARISTADA, Qelbree, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
